Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Ventricular Catheter Ablation Study (VCAS)

NCT: NCT06203262 · COMPLETED

NCT IDNCT06203262
StatusCOMPLETED
Start Date2024-04-12
Completion2025-11-28

Brief Summary

This is a prospective safety and feasibility study to evaluate the safety of the FieldForce™ Ablation system in patients with ventricular arrhythmia divided into two groups: VT (VCAS-I) and frequent premature ventricular complex (VCAS-II).

Frequently Asked Questions

What is Ventricular Catheter Ablation Study (VCAS)?

Ventricular Catheter Ablation Study (VCAS) is a clinical trial registered under NCT06203262. Current status: COMPLETED.

What is the status of NCT06203262?

The current status of NCT06203262 (Ventricular Catheter Ablation Study (VCAS)) is: COMPLETED.

When did Ventricular Catheter Ablation Study (VCAS) start?

Ventricular Catheter Ablation Study (VCAS) started on 2024-04-12.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.